HMS Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

HMS Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,269	Closed	-$329K	–	123
2021 Q4	$329K	Sell	5,269 -450	-8%	-$26.4K	0.14%	107
2021 Q3	$338K	Buy	5,719 +38	+0.7%	+$2.5K	0.16%	108
2021 Q2	$380K	Buy	5,681 +591	+12%	+$38.5K	0.17%	110
2021 Q1	$321K	Sell	5,090 -1,141	-18%	-$71K	0.14%	103
2020 Q4	$386K	Sell	6,231 -867	-12%	-$53.3K	0.18%	95
2020 Q3	$428K	Sell	7,098 -109	-2%	-$6.56K	0.17%	111
2020 Q2	$424K	Buy	7,207 +2,642	+58%	+$158K	0.19%	111
2020 Q1	$254K	Buy	+4,565	New	+$279K	0.25%	70
2019 Q4	–	Sell	-4,840	Closed	-$300K	–	174
2019 Q3	$300K	Buy	4,840 +3,840	+384%	+$180K	0.11%	167
2019 Q2	$45K	Buy	+1,000	New	+$46.6K	0.02%	223
2019 Q1	–	Sell	-9,680	Closed	-$552K	–	179
2018 Q4	$552K	Buy	9,680 +4,840	+100%	+$260K	0.28%	92
2018 Q3	$300K	Buy	4,840 +1,000	+26%	+$59.3K	0.15%	156
2018 Q2	$213K	Buy	+3,840	New	+$207K	0.12%	166

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

HMS Capital Management's BMY Position: Q1 2022 in Review

HMS Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 5,269 shares — an estimated $329K sold.

HMS Capital Management first reported a position in BMY in Q2 2018 and held it in 13 quarters. The position peaked at $552K in Q4 2018. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

HMS Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
HMS Capital Management sold 5,269 Bristol-Myers Squibb shares in Q1 2022, an estimated $329K.
HMS Capital Management first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 13 quarters.
HMS Capital Management's Bristol-Myers Squibb position peaked at $552K in Q4 2018.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on HMS Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.